Kojin Therapeutics

1 follower

‌

Kojin is pioneering cell-state and ferroptosis biology and cutting-edge drug discovery to develop first-in-class small-molecule treatments that modulate ferroptosis.

Industries

Biotechnology

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Harvey J. Berger

Chairman, Chief Executive Officer & President

Harvey J. Berger

Collapse

Horst Hemmerle

SVP & Chief Scientific Officer

David Dalgarno

SVP, Digital & Data Science and Technology

Sally Kokernak Millwood

Senior Administrative And Operations Manager

Teams

CEO and Executive Team

5 members

Founding Team

4 members

Similar companies

Enko

4 followers

Tango Therapeutics

2 followers

Kyverna Therapeutics

6 followers

Ultima Genomics

3 followers

Cellares

2 followers

BioXcellerator

1 follower

ACELYRIN

1 follower

Thermo Fisher Scientific

173 followers

Gilead Sciences

133 followers

Biogen

118 followers

Regeneron

101 followers

Explore companies